Pituitary Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Pituitary cancer arising from the anterior pituitary gland accounts for approximately 15% of intracranial neoplasms and is typically benign. However, these tumors may metastasize and be referred to as pituitary carcinoma in rare cases. The underlying etiology of pituitary gland tumors is not fully understood but likely involves genetic abnormalities and alterations. Hereditary conditions such as multiple endocrine neoplasias (MEN)-1 syndrome are associated with an increased risk of pituitary tumors. The pathophysiology of pituitary cancer is believed to be genetically related, but specific gene mutations have yet to be fully identified. Pituitary tumors may be functional, secreting hormones and causing particular symptoms, or non-functional, without hormone production. The clinical presentation of pituitary tumors can include symptoms related to the mass effect on surrounding structures, such as the optic chiasm or cavernous sinus. Surgery is the primary treatment for pituitary...